The role of oncovascular surgery in gynecologic oncology surgery
![](https://ptgo.edu.pl/wp-content/uploads/2020/11/Zrzut-ekranu-2020-11-16-o-23.01.13.png)
Nomogram to predict feasibility of minimally invasive interval debulking surgery in advanced ovarian cancer
![](https://ptgo.edu.pl/wp-content/uploads/2020/11/Zrzut-ekranu-2020-11-16-o-23.01.13.png)
Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers
![](https://ptgo.edu.pl/wp-content/uploads/2020/11/Zrzut-ekranu-2020-11-16-o-23.01.13.png)
Validation of the 2021 FIGO staging schema for advanced vulvar cancer
![](https://ptgo.edu.pl/wp-content/uploads/2020/11/Zrzut-ekranu-2020-11-16-o-23.01.13.png)
Quality of training in cervical cancer radical surgery: a survey from the European Network of Young Gynaecologic Oncologists (ENYGO)
![](https://ptgo.edu.pl/wp-content/uploads/2020/11/Zrzut-ekranu-2020-11-16-o-23.01.13.png)
The effect of complete surgical staging and adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid ovarian carcinoma
![](https://ptgo.edu.pl/wp-content/uploads/2020/11/Zrzut-ekranu-2020-11-16-o-23.01.13.png)
Cervical cancer after LACC: a combination of surgical strategies
![](https://ptgo.edu.pl/wp-content/uploads/2020/11/Zrzut-ekranu-2020-11-16-o-23.01.13.png)
Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001
![](https://ptgo.edu.pl/wp-content/uploads/2020/11/Zrzut-ekranu-2020-11-16-o-23.01.13.png)
Human papillomavirus-independent cervical cancer
![](https://ptgo.edu.pl/wp-content/uploads/2020/11/Zrzut-ekranu-2020-11-16-o-23.01.13.png)
Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial
![](https://ptgo.edu.pl/wp-content/uploads/2021/02/lancet.jpg)